Legis Daily

Pharmacy Benefits Manager Accountability Act

USA118th CongressHR-2679| House 
| Updated: 12/17/2024
Ann M. Kuster

Ann M. Kuster

Democratic Representative

New Hampshire

Cosponsors (5)
Brett Guthrie (Republican)Marie Gluesenkamp Perez (Democratic)Earl L. "Buddy" Carter (Republican)Jake Auchincloss (Democratic)Anna G. Eshoo (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee, Education and Workforce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Pharmacy Benefits Manager Accountability Act This bill establishes reporting requirements for pharmacy benefit managers (PBMs) with respect to services provided to health insurance plans. First, PBMs must report annually to the plan sponsor certain information about the PBM's services, including the amount of prescription drug copayment assistance funded by drug manufacturers, a list of covered drugs billed under the plan during the reporting period, and the total gross and net spending by the health plan on prescription drugs during the reporting period. PBMs also must submit specified elements of the report (e.g., the total gross spending on prescription drugs) to the Government Accountability Office (GAO). The report must comply with the privacy requirements under the Health Insurance Portability and Accountability Act of 1996. The bill establishes civil penalties for violations of these requirements and provides for enforcement by the appropriate agencies. GAO must report on the pharmacy networks of plans or PBMs, including whether such networks under common ownership with the plans or PBMs are designed to encourage plan enrollees to use network pharmacies over other pharmacies.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 18, 2023
Introduced in House
Apr 18, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • April 18, 2023
    Introduced in House


  • April 18, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 17, 2024
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 118-3561: PATIENT Act of 2023
  • HR 118-4846: Better Deals and Lower Prices Act
  • HR 118-4822: Health Care Price Transparency Act of 2023
Business recordsCivil actions and liabilityEmployee benefits and pensionsGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth information and medical recordsPrescription drugsRight of privacy

Pharmacy Benefits Manager Accountability Act

USA118th CongressHR-2679| House 
| Updated: 12/17/2024
Pharmacy Benefits Manager Accountability Act This bill establishes reporting requirements for pharmacy benefit managers (PBMs) with respect to services provided to health insurance plans. First, PBMs must report annually to the plan sponsor certain information about the PBM's services, including the amount of prescription drug copayment assistance funded by drug manufacturers, a list of covered drugs billed under the plan during the reporting period, and the total gross and net spending by the health plan on prescription drugs during the reporting period. PBMs also must submit specified elements of the report (e.g., the total gross spending on prescription drugs) to the Government Accountability Office (GAO). The report must comply with the privacy requirements under the Health Insurance Portability and Accountability Act of 1996. The bill establishes civil penalties for violations of these requirements and provides for enforcement by the appropriate agencies. GAO must report on the pharmacy networks of plans or PBMs, including whether such networks under common ownership with the plans or PBMs are designed to encourage plan enrollees to use network pharmacies over other pharmacies.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 18, 2023
Introduced in House
Apr 18, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • April 18, 2023
    Introduced in House


  • April 18, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 17, 2024
    Referred to the Subcommittee on Health.
Ann M. Kuster

Ann M. Kuster

Democratic Representative

New Hampshire

Cosponsors (5)
Brett Guthrie (Republican)Marie Gluesenkamp Perez (Democratic)Earl L. "Buddy" Carter (Republican)Jake Auchincloss (Democratic)Anna G. Eshoo (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee, Education and Workforce Committee

Health

Related Bills

  • HR 118-3561: PATIENT Act of 2023
  • HR 118-4846: Better Deals and Lower Prices Act
  • HR 118-4822: Health Care Price Transparency Act of 2023
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsCivil actions and liabilityEmployee benefits and pensionsGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth information and medical recordsPrescription drugsRight of privacy